Xiaojun Lu

3.9k citations
111 papers · 2.9k · 1 hit paper · h-index 26

Impact in

Papers in

Xiaojun Lu

108 papers receiving 2.8k citations

Xiaojun Lu's Hit Papers

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial 2016 · 424 citations
4240+3+6Years since publication100200300400

Peers

Xiaojun Lu
Comparison fields: 5 of 114
  • Otorhinolaryngology 344
  • Cancer Research 344
  • Insect Science 204
  • Infectious Diseases 240
  • Epidemiology 330
Replace Jing Lin with:
Jing Lin China
Matthew A. Vadas Australia
Sun Ying United Kingdom
Beate Rückert Switzerland
François Fossiez France
Chi‐Neu Tsai Taiwan
Koubun Yasuda Japan
Brian W. P. Seymour United States
Arnold H. Zea United States
Inès Schmid Switzerland
Xiaojun Lu relative to Jing Lin China Jing Lin's profile →
Citations per field
00.5×2×4×5.7×
Jing Lin · 1×
Citations per year

Countries citing papers authored by Xiaojun Lu

Since Specialization
Citations

This map shows the geographic impact of Xiaojun Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojun Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojun Lu more than expected).

Fields of papers citing papers by Xiaojun Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojun Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojun Lu. The network helps show where Xiaojun Lu may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaojun Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaojun Lu Line = papers co-authored together Xiaojun Lu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
Hit paper breakdown →
2016424
2 2008244
3 2001242
4 2011174
5 202185
6 200580
7 201979
8 201578
9 202073
10 200869
11 201465
12 201962
13 201458
14 201242
15 201340
16 202240
17 201338
18 201535
19 201534
20 201734

About Xiaojun Lu

Xiaojun Lu is a scholar working on Cancer Research, Infectious Diseases, Hematology, Pulmonary and Respiratory Medicine and Insect Science, having authored 111 papers that have together received 2.9k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (16 papers), MicroRNA in disease regulation (11 papers), Chronic Myeloid Leukemia Treatments (5 papers), Acute Myeloid Leukemia Research (4 papers), Hepatitis B Virus Studies (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Forensic Entomology and Diptera Studies (3 papers). The work is most often cited by research in Otorhinolaryngology (344 citations), Cancer Research (344 citations), Insect Science (204 citations), Infectious Diseases (240 citations) and Epidemiology (330 citations). Xiaojun Lu has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Binwu Ying, Xingbo Song, Andrew S. Kraft, Yuri Ivashchenko, Gary J. Miller, Alexandre Nesterov, Lanlan Wang, Guanghui Wang, Haigang Ren and Xuejiao Lina Hu. Their work appears in journals such as Infection Genetics and Evolution, PLoS ONE, Molecular Biology Reports, Tumor Biology and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact